Sort
51,570 grants matching “autoimmune disease”
The Role of Rare Variants in Multiple Sclerosis Risk
$961,201David A. Hafler · Yale University · RC2 · FY2009 · NS
Long Acting Native GLP-1 formulations for Type 1 Diabetes
$960,879Elijah M. Bolotin · Pharmain Corporation · R44 · FY2008 · DK
Advancing an accessible, high-throughput and multiplex islet autoantibody test with self-collected capillary dried blood spots for regulatory clearance
$960,753David Seftel · Enable Biosciences, Inc. · R44 · FY2025 · DK
Structural Studies of Pattern Recognition Receptors
$960,513Tsan Xiao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Improving Outcomes Assessment in Chronic Graft versus Host Disease
$960,249Stephanie J Lee · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Apoptosis
$960,244John A. Cidlowski · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
Genetic mechanisms of type 1 diabetes risk in stress-induced pancreatic islets
$960,228Kyle Jeffrie Gaulton · University Of California, San Diego · R01 · FY2021 · DK
Genetic mechanisms of type 1 diabetes risk in stress-induced pancreatic islets
$960,228Kyle Jeffrie Gaulton · University Of California, San Diego · R01 · FY2022 · DK
Biologic correlatives of chronic GVHD onset
$959,842Stephanie J Lee · Fred Hutchinson Cancer Center · U01 · FY2022 · CA
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$959,375Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2023 · AI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$959,375Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2022 · AI
Long Acting Native GLP-1 formulations for Type 1 Diabetes
$959,053Elijah M. Bolotin · Pharmain Corporation · R44 · FY2009 · DK
How Does blockade of CD40/CD40L Prevent Autoimmunity?
$958,901La Jolla Inst For Allergy &Immunolgy · U19 · FY2005 · AI
Evaluation of clinical samples for virus detection for mechanism of CNS disease
$958,863Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS
Intracellular Signaling By The Cell Surface Receptor For IgE
$958,808Juan Rivera · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2012 · AR
MULTIPURPOSE ARTHRITIS &MUSCULOSKELETAL DISEASES CENTER
$958,687University Of North Carolina Chapel Hill · P60 · FY2000 · AR
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$958,345Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2024 · AI
Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome
$957,638Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Improving Outcomes Assessment in Chronic Graft versus Host Disease
$957,625Stephanie J Lee · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
The Role of Rare Variants in Multiple Sclerosis Risk
$956,785David A. Hafler · Yale University · RC2 · FY2010 · NS
A Novel Probiotic for the Treatment of Sjogren's Syndrome
$956,644Gary Fanger · Rise Therapeutics, Llc · R44 · FY2019 · DE
MOLECULAR BASIS OF IDIOPATHIC DRY MOUTH
$956,342University Of Rochester · P01 · FY2003 · DE
Pathophysiology of HTLV-I and HTLV-II Infection
$956,255University Of California San Francisco · R01 · FY2005 · HL
A Novel Immunological-Directed Synthetic Biology-Based Drug for the Treatment of Multiple Sclerosis
$956,049Christian Furlan Freguia · Rise Therapeutics, Llc · R44 · FY2024 · AI
Basic Research Support for the CCR
$955,878Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA